AVTX

Avalo Therapeutics Inc

May 19 • 04:00PM ET

16.27

+0.11 0.68 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ZURA COGT AUPH KYTX ARQT

| Held by: VTI VXF IWC ITOT TMSL DFAS DFMC TMED BMED TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.82	Insider Own	14.36%	Shs Outstand	52.57M	Perf Week	-18.41%
Market Cap	855.24M	Forward P/E	-	EPS next Y	-3.11	Insider Trans	-4.04%	Shs Float	45.02M	Perf Month	10.98%
Enterprise Value	775.43M	PEG	-	EPS next Q	-0.62	Inst Own	56.99%	Short Float	12.74%	Perf Quarter	8.47%
Income	-84.74M	P/S	14254.00	EPS this Y	45.93%	Inst Trans	18.80%	Short Ratio	4.08	Perf Half Y	7.68%
Sales	0.06M	P/B	5.87	EPS next Y	1.62%	ROA	-71.09%	Short Interest	5.73M	Perf YTD	-10.41%
Book/sh	2.77	P/C	10.41	EPS next 5Y	21.02%	ROE	-88.76%	52W High	24.27 -32.96%	Perf Year	306.75%
Cash/sh	1.56	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-120.51%	52W Low	3.43 374.16%	Perf 3Y	-98.01%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-283.05%	Volatility	9.32% 10.65%	Perf 5Y	-99.78%
Dividend TTM	-	EV/Sales	12923.83	EPS Y/Y TTM	-1121.44%	Oper. Margin	-134164.41%	ATR (14)	1.75	Perf 10Y	-99.84%
Dividend Ex-Date	-	Quick Ratio	7.66	Sales Y/Y TTM	-86.62%	Profit Margin	-143627.12%	RSI (14)	47.49	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.66	EPS Q/Q	21.93%	SMA20	-3.23%	Beta	0.80	Target Price	46.18
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	4.10%	Rel Volume	1.17	Prev Close	16.16
Employees	33	LT Debt/Eq	0.03	Earnings	May 13 BMO	SMA200	8.69%	Avg Volume	1.41M	Price	16.27
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.42% -	Trades		Volume	1,670,960	Change	0.68%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)